top of page
attack MS logo1_edited.png
smileyface1_edited.png

Turbo Charging  treatment for newly-diagnosed Multiple Sclerosis

MS-Masters_KS-001-1_edited_edited_edited

AttackMS is a clinical trial  measuring the effectiveness of treating

newly-diagnosed Multiple Sclerosis

with a stronger drug to delay MS progression

MS research shows that earlier treatment with an MS  disease-modifying treatment can slow progression.

baker_edited.png

The AttackMS trial

3 London recruitment hospitals

​

​

​

Patients

stories 1

The AttackMS Trial

bottom of page